Arcus Biosciences Inc
NYSE:RCUS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Arcus Biosciences Inc
NYSE:RCUS
|
US |
|
B
|
Bank Mandiri (Persero) Tbk PT
OTC:PPERY
|
ID |
|
B
|
Barings BDC Inc
F:TRY
|
US |
|
ANZ Group Holdings Ltd
OTC:ANZGF
|
AU |
|
M
|
Moody's Corp
F:DUT
|
US |
|
Fox Corp
F:FO5
|
US |
|
L
|
Lenovo Group Ltd
F:LHL
|
CN |
|
Z
|
Ziprecruiter Inc
F:47R
|
US |
|
D
|
DXC Technology Co
F:2XT
|
US |
|
L
|
Lowe's Companies Inc
F:LWE
|
US |
|
China Resources Beer Holdings Co Ltd
F:CHK0
|
HK |
|
H
|
Helmerich and Payne Inc
XMUN:HPC
|
US |
|
Datang International Power Generation Co Ltd
SSE:601991
|
CN |
|
T
|
Tx Group Ltd
OTC:TDAAF
|
CH |
|
R
|
Royal Bank of Canada
XMUN:RYC
|
CA |
Bankruptcy Probability
Arcus Biosciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Arcus Biosciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Arcus Biosciences Inc
NYSE:RCUS
|
3.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
464.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
181.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
83.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
57.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
50.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Arcus Biosciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Arcus Biosciences Inc has total debt of 101m USD. This includes both short-term (0 USD) and long-term (101m USD) debt.
You can find a full breakdown on its Balance Sheet.